FDA.reportPublic FDA data

NDC 71872-7027-01 - Cefazolin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
71872-7027
Requested NDC
71872-7027-01
Package NDCs from labels
71872-7027-1, 71872-7027-01
Manufacturer
Medical Purchasing Solutions, LLC
Effective date
2023-06-01
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Cefazolin - Medical Purchasing Solutions, LLCMedical Purchasing Solutions, LLC2023-06-01HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71872-7027-1Cefazolin3 mL in 1 VIALINJECTION, POWDER, FOR SOLUTION33
71872-7027-1Cefazolin1 in 1 BAGINJECTION, POWDER, FOR SOLUTION13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71872-7027CEFAZOLIN INJECTION, POWDER, FOR SOLUTION [MEDICAL PURCHASING SOLUTIONS, LLC]3Current NDC, Legacy NDC, 2 package rows20230602_6673be13-4c74-70b9-e053-2a91aa0a211d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 32 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CefazolinCEFAZOLINHikma Pharmaceuticals USA Inc.26de1ce9-06a9-486f-b27d-2ac635f018d12026-05-14Warnings, Adverse reactionsExact identifier
application number: ANDA065047
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINCivica, Inc.9ea55207-6d86-401e-b9b9-73c9534a233f2026-05-14Warnings, Adverse reactionsExact identifier
application number: ANDA065047
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINHikma Pharmaceuticals USA Inc.1dc9de56-e259-4546-a1db-23119a8a088e2026-05-14Warnings, Adverse reactionsExact identifier
application number: ANDA065047
ndc (product): 0143-9924
rxcui: 1665052
rxcui: 1665050
spl id: 6cdaf80f-9ba2-4b0f-903d-61e0811ffaae
spl set id: 1dc9de56-e259-4546-a1db-23119a8a088e
unii: P380M0454Z
CefazolinCEFAZOLINWG Critical Care, LLC4f3a9248-a354-4c77-bf5b-9eed38f002192026-02-27Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINHospira, Inc62441488-fc97-4535-a249-4485fb0750222026-01-21Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINWG Critical Care, LLC00dd6da7-50a8-44c9-b2dc-7948973df3922026-01-07Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINCivica, Inc.c24e604f-16ca-4945-8e9d-277cc67a8c682025-11-20Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINCivica, Inc.1367568c-7d27-479f-a4c5-58e99942f6862025-11-01Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CEFAZOLINCEFAZOLINHenry Schein, Inc.197d5702-2c20-480e-8246-4d0d21f871be2025-10-27WarningsExact identifier
application number: ANDA065047
rxcui: 1665050
unii: P380M0454Z
CEFAZOLINCEFAZOLINHenry Schein Inc.922fb1a1-ad4c-4a12-8d5d-00fe13af18e82025-10-27Warnings, Adverse reactionsExact identifier
application number: ANDA065047
rxcui: 1665052
unii: P380M0454Z
CEFAZOLINCEFAZOLINHenry Schein, Inc.5a8c4bb2-a75e-4d7d-91fb-9a95f04fc94b2025-10-27Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINProPharma Distribution3d5cc73c-8a41-b285-e063-6294a90a609f2025-08-27Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINHikma Pharmaceuticals USA Inc.570d2583-9ce7-4941-bf7c-6ebc783c0f2b2025-07-25Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINApotex Corp.0422fe47-c372-494f-bac2-612f550b44a42025-07-15Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINWG Critical Care, LLCf17160d4-fc42-4f9c-abb8-d04f01ae6dd12025-04-07Warnings, Adverse reactionsExact identifier
rxcui: 1665052
rxcui: 1665050
unii: P380M0454Z
Cefazolin SodiumCEFAZOLIN SODIUMB. Braun Medical Inc.17f8f038-c204-4dab-80d7-6f7ac41ddbec2025-03-10Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINSandoz Inc18e7366a-1b3e-4010-8f4a-dd559d4f21462025-02-05Warnings, Adverse reactionsExact identifier
rxcui: 1665052
rxcui: 1665050
unii: P380M0454Z
CEFAZOLINCEFAZOLIN SODIUMSamson Medical Technologies, L.L.C.cf13db9c-d8a1-489f-9aa0-fc70839d4bbc2025-01-08Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINHikma Pharmaceuticals USA Inc.6c7761d3-c154-4802-9876-627cd42913f02024-12-31Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
Cefazolin SodiumCEFAZOLIN SODIUMDirect_rx22dfc2e4-07a7-8d13-e063-6394a90a3e9f2024-09-24Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.